Neurodevelopmental outcome after intrauterine red cell transfusion for Parvovirus B19-induced fetal hydrops

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 109, Issue 11, 2002, Pages 1232-1234

  Dembinski, J ^a   Haverkamp, F ^b   Maara, H ^b   Hansmann, M ^b   Eis Hubinger A M ^b   Bartmann, P ^b  

^a UNIVERSITY OF BONN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; CHILD; CLINICAL ARTICLE; DEVELOPMENTAL DISORDER; ERYTHROCYTE TRANSFUSION; FEMALE; FETUS; FETUS HYDROPS; FOLLOW UP; HUMAN; INTELLIGENCE QUOTIENT; INTRAUTERINE BLOOD TRANSFUSION; MALE; MEDICAL RECORD; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; PARVOVIRUS; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME; VIRUS INFECTION;

BLOOD TRANSFUSION, INTRAUTERINE; CHILD; CHILD DEVELOPMENT; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; HYDROPS FETALIS; INTELLIGENCE; MALE; MULTIVARIATE ANALYSIS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 0036876443     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-0528.2002.02118.x     Document Type: Article

References (25)

1. Brown K.E. Haematological consequences of parvovirus B19 infection. Baillieres Best Pract Res Clin Haematol. 13(2):2000;245-259. June.
2. Gilbert G.L. Parvovirus B19 infection and its significance in pregnancy. Commun Dis Intell. 24(Suppl):2000;69-71. March.
3. Labouret N., Cecille A., Wendling M.J., Fritsch S., Gut J.P., Stoll-Keller F. Prenatal diagnosis of viral infections. A two year study in Strasbourg. Pathol Biol (Paris). 47(5):1999;526-530. May.
4. Dong Z.W., Zhou S.Y., Li Y., Liu R.M. Detection of a human parvovirus intrauterine infection with the polymerase chain reaction. J Reprod Med. 45(5):2000;410-412. May.
5. Schild R.L., Bald R., Plath H., Eis-Hubinger A.M., Enders G., Hansmann M. Intrauterine management of fetal parvovirus B19 infection. Ultrasound Obstet Gynecol. 13(3):1999;161-166. March.
6. Rodis J.F., Borgida A.F., Wilson Met al. Management of parvovirus infection in pregnancy and outcomes of hydrops: a survey of members of the Society of Perinatal Obstetricians. Am J Obstet Gynecol. 179(4):1998;985-988. October.
7. Hansmann M., Gembruch U., Bald R. New therapeutic aspects in nonimmune hydrops fetalis based on four hundred and two prenatally diagnosed cases. Fetal Ther. 4(1):1989;29-36.
8. Schwarz T.F., Roggendorf M., Hottentrager Bet al. Human parvovirus B19 infection in pregnancy. Lancet. 2(8610):1988;566-567. September 3.
9. Hansmann M. Controlled ultrasound therapy of the fetus. Arch Gynecol. 238(1-4):1985;169-184.
10. Forestier F., Tissot J.D., Vial Y., Daffos F., Hohlfeld P. Haematological parameters of parvovirus B19 infection in 13 fetuses with hydrops foetalis. Br J Haematol. 104(4):1999;925-927. March.
11. Odibo A.O., Campbell W.A., Feldman Det al. Resolution of human parvovirus B19-induced nonimmune hydrops after intrauterine transfusion. J Ultrasound Med. 17(9):1998;547-550. September.
12. Cameron A.D., Swain S., Patrick W.J. Human parvovirus B19 infection associated with hydrops fetalis. Aust N Z J Obstet Gynaecol. 37(3):1997;316-319. August.
13. de Krijger R.R., van Elsacker-Niele A.M., Mulder-Stapel Aet al. Detection of parvovirus B19 infection in first and second trimester fetal loss. Pediatr Pathol Lab Med. 18(1):1998;23-34. January-February.
14. Vogel H., Kornman M., Ledet S.C., Rajagopalan L., Taber L., McClain K. Congenital parvovirus infection. Pediatr Pathol Lab Med. 17(6):1997;903-912. November-December.
15. Isumi H., Nunoue T., Nishida A., Takashima S. Fetal brain infection with human parvovirus B19. Pediatr Neurol. 21(3):1999;661-663. September.
16. Plachouras N., Stefanidis K., Andronikou S., Lolis D. Severe nonimmune hydrops fetalis and congenital corneal opacification secondary to human parvovirus B19 infection. A case report. J Reprod Med. 44(4):1999;377-380. April.
17. Zerbini M., Gentilomi G.A., Gallinella Get al. Intra-uterine parvovirus B19 infection and meconium peritonitis. Prenat Diagn. 18(6):1998;599-606. June.
18. Doyle L.W., Kelly E.A., Rickards A.L., Ford G.W., Callanan C. Sensorineural outcome at 2 years for survivors of erythroblastosis treated with fetal intravascular transfusions. Obstet Gynecol. 81(6):1993;931-935. June.
19. Hudon L., Moise K.J. Jr., Hegemier SEet al. Long-term neurodevelopmental outcome after intrauterine transfusion for the treatment of fetal hemolytic disease. Am J Obstet Gynecol. 179(4):1998;858-863. October.
20. Brandt I. Griffiths Entwicklungsskalen (GES) zur Beurteilung der Entwicklung in den ersten beiden Lebensjahren/dt. Bearb. Ingeborg Brandt. Weinheim; Basel:Beltz, 1983.
21. Harris S.H. An evaluation of the Snijders-Oomen Nonverbal Intelligence Scale for Young Children. J Pediatr Psychol. 7(3):1982;239-251. September.
22. Melchers P., Preuss U. Revision of the Kaufman Assessment Battery for Children for German speaking regions. Part 2: Areas of application and criteria of reliability. Z Kinder Jugendpsychiatr. 20(4):1992;223-231. December.
23. Melchers P., Preuss U. Adaptation of the Kaufman Assessment Battery for Children for German-speaking areas. Part 1: Introduction of the battery. Z Kinder Jugendpsychiatr. 20(2):1992;85-93. June, German.
24. Wolke D. Die intellektuelle Entwicklung im Längsschnitt: Der prognostische Wert früher Entwicklungstests. Leyendecker C., Horstmann T. Frühförderung und Frühbehandlung. 1997;279-288 Universitaetsverlag C, Heidelberg. Winter.
25. Largo R.H., Graf S., Kundu S., Hunziker U., Molinari L. Predicting developmental outcome at school age from infant tests in normal, at risk and retarded children. Dev Med Child Neurol. 32:1990;30-45.